IDiyas

For the Inventor, By the Inventor

Migne-Auxances, France

Jean-Bernard Fourtillan

USPTO Granted Patents = 7

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 45(Granted Patents)


Location History:

  • Migne-Auxances, FR (1998 - 2000)
  • Bordeaux, FR (2007)
  • Poitiers, FR (2002 - 2020)

Company Filing History:

goldMedal2 out of 3 
 
Cemaf
 patents
silverMedal1 out of 2 
 
Laboratories Besins Iscovesco
 patents
bronzeMedal1 out of 1 
 
Cemaf and Laboratoires Besins Iscovesco S.a.
 patent
4. 1 out of 1 
 
Macef
 patent
5. 1 out of 1 
 
Cemaf and Laboratories Besins Isovesco S.a.
 patent
6. 1 out of 1 
 
Laboratories Besins-iscovesco S.a.
 patent
7. 2 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1998-2020

Loading Chart...
7 patents (USPTO):Explore Patents
1. 10744122 - Transdermal therapeutic system containing valentonin and use thereof as a medicament (2020-08-18),
2. 7291627 - Dihydroimidazo[5.1-a]-beta-carboline derivatives, method for their preparation, and their application as a drug (2007-11-06),
3. 6335346 - Pyrrolo-(3,4-b)quinoline derivatives, method for the production and use thereof as a medicament (2002-01-01),
4. 6140372 - Acyl derivatives of melatonin and of melatoninergic analogues and their (2000-10-31),
5. 6066663 - Oxidation derivatives of indolylalkylamines and their use as drugs (2000-05-23),
6. 6004991 - Acylated derivatives of melationin and its analogues, useful as (1999-12-21),
7. 5763471 - Melatoninergic agonist spiro �indolepyrrolidine! derivatives, process (1998-06-09),

Title: The Innovative Contributions of Jean-Bernard Fourtillan

Introduction

Jean-Bernard Fourtillan is a notable inventor based in Migne-Auxances, France. He has made significant contributions to the field of medicine through his innovative inventions. With a total of 7 patents, Fourtillan has focused on developing therapeutic systems and compounds that have potential applications in medical treatments.

Latest Patents

Among his latest patents is the "Transdermal therapeutic system containing valentonin and use thereof as a medicament." This invention relates to an adhesive transdermal therapeutic system that utilizes an association of valentonin (VLT) and 6-methoxyharmalan (6-MH) as its active principle. Another significant patent is for "Dihydroimidazo[5.1-a]-beta-carboline derivatives, method for their preparation, and their application as a drug." This invention concerns dihydroimidazo[-a]-β-carboline compounds, which are designed for use in medicine, particularly as hypnotics.

Career Highlights

Throughout his career, Jean-Bernard Fourtillan has worked with various companies, including Cemaf. His work has been instrumental in advancing therapeutic technologies and improving patient care through innovative drug delivery systems.

Collaborations

Fourtillan has collaborated with notable individuals in his field, including Marianne Fourtillan and Jean-Claude Jacquesy. These collaborations have contributed to the development and refinement of his inventions.

Conclusion

Jean-Bernard Fourtillan's contributions to the field of medicine through his patents highlight his innovative spirit and dedication to improving healthcare. His work continues to influence the development of new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…